Cargando…
Mathematical models for translational and clinical oncology
In the context of translational and clinical oncology, mathematical models can provide novel insights into tumor-related processes and can support clinical oncologists in the design of the treatment regime, dosage, schedule, toxicity and drug-sensitivity. In this review we present an overview of mat...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828625/ https://www.ncbi.nlm.nih.gov/pubmed/24195863 http://dx.doi.org/10.1186/2043-9113-3-23 |
_version_ | 1782291271531888640 |
---|---|
author | Gallasch, Ralf Efremova, Mirjana Charoentong, Pornpimol Hackl, Hubert Trajanoski, Zlatko |
author_facet | Gallasch, Ralf Efremova, Mirjana Charoentong, Pornpimol Hackl, Hubert Trajanoski, Zlatko |
author_sort | Gallasch, Ralf |
collection | PubMed |
description | In the context of translational and clinical oncology, mathematical models can provide novel insights into tumor-related processes and can support clinical oncologists in the design of the treatment regime, dosage, schedule, toxicity and drug-sensitivity. In this review we present an overview of mathematical models in this field beginning with carcinogenesis and proceeding to the different cancer treatments. By doing so we intended to highlight recent developments and emphasize the power of such theoretical work. We first highlight mathematical models for translational oncology comprising epidemiologic and statistical models, mechanistic models for carcinogenesis and tumor growth, as well as evolutionary dynamics models which can help to describe and overcome a major problem in the clinic: therapy resistance. Next we review models for clinical oncology with a special emphasis on therapy including chemotherapy, targeted therapy, radiotherapy, immunotherapy and interaction of cancer cells with the immune system. As evident from the published studies, mathematical modeling and computational simulation provided valuable insights into the molecular mechanisms of cancer, and can help to improve diagnosis and prognosis of the disease, and pinpoint novel therapeutic targets. |
format | Online Article Text |
id | pubmed-3828625 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-38286252013-11-16 Mathematical models for translational and clinical oncology Gallasch, Ralf Efremova, Mirjana Charoentong, Pornpimol Hackl, Hubert Trajanoski, Zlatko J Clin Bioinforma Review In the context of translational and clinical oncology, mathematical models can provide novel insights into tumor-related processes and can support clinical oncologists in the design of the treatment regime, dosage, schedule, toxicity and drug-sensitivity. In this review we present an overview of mathematical models in this field beginning with carcinogenesis and proceeding to the different cancer treatments. By doing so we intended to highlight recent developments and emphasize the power of such theoretical work. We first highlight mathematical models for translational oncology comprising epidemiologic and statistical models, mechanistic models for carcinogenesis and tumor growth, as well as evolutionary dynamics models which can help to describe and overcome a major problem in the clinic: therapy resistance. Next we review models for clinical oncology with a special emphasis on therapy including chemotherapy, targeted therapy, radiotherapy, immunotherapy and interaction of cancer cells with the immune system. As evident from the published studies, mathematical modeling and computational simulation provided valuable insights into the molecular mechanisms of cancer, and can help to improve diagnosis and prognosis of the disease, and pinpoint novel therapeutic targets. BioMed Central 2013-11-07 /pmc/articles/PMC3828625/ /pubmed/24195863 http://dx.doi.org/10.1186/2043-9113-3-23 Text en Copyright © 2013 Gallasch et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Gallasch, Ralf Efremova, Mirjana Charoentong, Pornpimol Hackl, Hubert Trajanoski, Zlatko Mathematical models for translational and clinical oncology |
title | Mathematical models for translational and clinical oncology |
title_full | Mathematical models for translational and clinical oncology |
title_fullStr | Mathematical models for translational and clinical oncology |
title_full_unstemmed | Mathematical models for translational and clinical oncology |
title_short | Mathematical models for translational and clinical oncology |
title_sort | mathematical models for translational and clinical oncology |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828625/ https://www.ncbi.nlm.nih.gov/pubmed/24195863 http://dx.doi.org/10.1186/2043-9113-3-23 |
work_keys_str_mv | AT gallaschralf mathematicalmodelsfortranslationalandclinicaloncology AT efremovamirjana mathematicalmodelsfortranslationalandclinicaloncology AT charoentongpornpimol mathematicalmodelsfortranslationalandclinicaloncology AT hacklhubert mathematicalmodelsfortranslationalandclinicaloncology AT trajanoskizlatko mathematicalmodelsfortranslationalandclinicaloncology |